基于非復(fù)制型腺病毒的新冠疫苗
基于mRNA的新冠疫苗
滅活病毒新冠疫苗
基于DNA技術(shù)的新冠疫苗
重組蛋白新冠疫苗
道阻且長(zhǎng),行則將至
參考資料:
[1] Draft landscape of COVID-19 candidate vaccines. Retrieved May 25, 2020, from //www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines
[2] Making sense of the deluge of early COVID-19 vaccine data. Retrieved May 25, 2020, from //www.biocentury.com/article/305272
[3] The world needs Covid-19 vaccines. It may also be overestimating their power. Retrieved May 25, 2020, from //www.statnews.com/2020/05/22/the-world-needs-covid-19-vaccines-it-may-also-be-overestimating-their-power/
[4] Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine. Retrieved May 25, 2020, from //ir.novavax.com/news-releases/news-release-details/novavax-initiates-phase-12-clinical-trial-covid-19-vaccine